This unique process has identified a number of important next steps in the areas of clinical practice guidelines, team-based models of care, health human resources and quality improvement.
Myelofibrosis is a chronic, debilitating myeloproliferative disorder characterized by progressive anemia, bone marrow fibrosis, splenomegaly, and constitutional symptoms.